BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9737826)

  • 61. One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study).
    Imafuku S; Nakayama J; Higa K; Furue M; Takahara M; Katayama I; Tani M
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1716-22. PubMed ID: 25564680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost effectiveness of newer antiviral agents for herpes zoster: is the evidence spotty?
    Smith KJ; Roberts MS
    J Infect Dis; 1998 Nov; 178 Suppl 1():S85-90. PubMed ID: 9852982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
    JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
    Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL;
    Cancer Invest; 2001; 19(1):13-22. PubMed ID: 11291551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
    Thackray AM; Field HJ
    J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Famciclovir as an antiviral agent for a patient with acute renal failure.
    Yoon H; Rhew KY
    Int J Clin Pharm; 2013 Apr; 35(2):173-5. PubMed ID: 23277418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir.
    Polansky H; Javaherian A; Itzkovitz E
    Drug Des Devel Ther; 2016; 10():2713-22. PubMed ID: 27621592
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successors to acyclovir.
    Easterbrook P; Wood MJ
    J Antimicrob Chemother; 1994 Sep; 34(3):307-11. PubMed ID: 7829405
    [No Abstract]   [Full Text] [Related]  

  • 71. Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.
    Vinh DC; Aoki FY
    Expert Opin Pharmacother; 2006 Nov; 7(16):2271-86. PubMed ID: 17059383
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contempo 1997: dermatology.
    Marks L; Saltzman R
    JAMA; 1997 Oct; 278(14):1148; author reply 1149. PubMed ID: 9326466
    [No Abstract]   [Full Text] [Related]  

  • 73. Famciclovir for the treatment of herpes zoster.
    Gordon A
    J Fam Pract; 1996 Apr; 42(4):350. PubMed ID: 8627199
    [No Abstract]   [Full Text] [Related]  

  • 74. Safety of antiviral medication for the treatment of herpes during pregnancy.
    Kang SH; Chua-Gocheco A; Bozzo P; Einarson A
    Can Fam Physician; 2011 Apr; 57(4):427-8. PubMed ID: 21490353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Famciclovir: efficacy in zoster and issues in the assessment of pain.
    Boon RJ; Griffin DR
    Adv Exp Med Biol; 1996; 394():17-31. PubMed ID: 8815684
    [No Abstract]   [Full Text] [Related]  

  • 76. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
    Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
    J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgia.
    Huse DM; Schainbaum S; Kirsch AJ; Tyring S
    Am J Health Syst Pharm; 1997 May; 54(10):1180-4. PubMed ID: 9161626
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Economic evaluation of antiviral therapy for the treatment of herpes zoster in immunocompetent adults.
    GrĂ¼ger J; Backhouse ME
    Pharmacoeconomics; 1997 Mar; 11(3):262-73. PubMed ID: 10165315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.